The meaning of “protected by a basic patent” has been clarified in Teva v Gilead, in a return to familiar ground The Court of Justice of the EU today clarified when a product is protected by a basic ...
The CJEU attempted to clarify the meaning of “protected by a basic patent” in Teva v Gilead, but practitioners and in-house counsel say it raises more questions than it has answered including a new ...
The Court of Justice of the European Union (CJEU) rendered a landmark decision extending patent term extensions for certain medicinal products in litigation relating to supplementary protection ...
I would like to thank USPTO Director John Squires for his initiative to stop serial patent challenges at the USPTO....
NEW YORK -- Pfizer Inc announced today that the U.S. Patent & Trademark Office has issued its first communication in the reexamination of the ‘893 basic patent for Lipitor, initially rejecting the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback